Because TLR4 and NF-κB/AP-1 signaling cascades play major roles in inflammatory responses caused by the infection of PAMPs such as LPS, regulating TLR4 and NF-κB/AP-1 is an attractive target for both acute and chronic inflammatory diseases [14,15,16]. The gene discussed is NFKB1; the disease is infection.